1987
DOI: 10.1055/s-2008-1052437
|View full text |Cite
|
Sign up to set email alerts
|

Reversible Symmetrical White Matter Low Attenuation in Rubella Encephalitis

Abstract: A ten-year-old Japanese boy, who fell ill with rubella encephalitis at 6 years of life, disclosed reversible symmetrical white matter low attenuation in both X-ray CT and 11C-glucose positron emission tomography (PET), which was newly applied to the illness. He recovered completely without neurological sequelae, similar in X-ray CT and PET.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…791 The scanning of a 10-yearold encephalitis patient with [U- 11 C]glucose, instead, showed a significant white matter low attenuation, indicating a regression in the cortical tissue, which, however, completely disappeared after recovery from the disease. 792 Regarding the detection of glioma brain tumors, clinical studies were carried out on 40 patients. 793 The detection of other brain tumors such as astrocytoma (grade II and anaplastic), oligoastrocytoma, or meningiomas, instead, was shown to be limited compared to other clinically-available radiopharmaceuticals (e.g., [ 11 C]methionine), especially for low-grade tumors.…”
Section: Sugarsmentioning
confidence: 99%
“…791 The scanning of a 10-yearold encephalitis patient with [U- 11 C]glucose, instead, showed a significant white matter low attenuation, indicating a regression in the cortical tissue, which, however, completely disappeared after recovery from the disease. 792 Regarding the detection of glioma brain tumors, clinical studies were carried out on 40 patients. 793 The detection of other brain tumors such as astrocytoma (grade II and anaplastic), oligoastrocytoma, or meningiomas, instead, was shown to be limited compared to other clinically-available radiopharmaceuticals (e.g., [ 11 C]methionine), especially for low-grade tumors.…”
Section: Sugarsmentioning
confidence: 99%